Esperion Therapeutics Inc. - ESPR - stock price prediction, stock price target, analyst ratings from 8 analysts

Esperion Therapeutics Inc. has a share price target of US$ 6, revenue growth forecast of 10.5%, and profit growth estimate of 67.5% for FY25, based on top 8 analyst calls.